Leptin and its potential role in human obesity

Journal of Internal Medicine

Volumn 245, Issue 6, 1999, Pages 643-652

  Lönnqvist, Fredrik ^a,b   Nordfors, L ^a   Schalling, M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adipose tissue; Db gene; Fat cells; Leptin; Ob gene; Obesity

Indexed keywords

LEPTIN; LEPTIN RECEPTOR;

ADIPOCYTE; APPETITE; CONFERENCE PAPER; ENERGY EXPENDITURE; FEEDBACK SYSTEM; GENE MUTATION; HORMONE ACTION; HUMAN; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR GENE;

EID: 0033037107     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1999.00493.x     Document Type: Conference Paper

References (66)

1. 1 Kaplan NM. The deadly quartet: Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989; 149: 1514-20.
2. 2 Bouchard C, Pérusse L. Genetics of obesity. Annu Rev Nutr 1993; 13: 337-54.
3. 3 Vogler GP, Sörensen TIA, Stunkard AJ, Srinivasan MR, Rao DC. Influences of genes and shared family environment on adult body mass index assessed in an adoption study by a comprehensive path model. Int J Obesity 1995; 19: 40-45.
4. 4 Stunkard AJ, Foch TT, Hrubec Z. A twin study of human obesity. JAMA 1986; 256: 1213-15.
5. 5 Brobeck JR. Food intake as mechanism of temperature regulation. Yale J Biol Med 1948; 20: 545-52.
6. 6 Kennedy GC. Role of depot fat in hypothalamic control of food intake in rat. Prof Royal Soc London B 1953; 140: 578-92.
7. 7 Ingalls AM, Dickie MM, Snell GD. Obese, new mutation in house mouse. J Hered 1950; 41: 317-18.
8. 8 Coleman DL. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978: 14: 141-8.
9. 9 Friedman JM, Leibel RD, Siegel DS, Walsh J, Bahary N. Molecular mapping of the mouse ob mutation. Genomics 1991; 11: 1054-62.
10. 10 Zhang Y, Proenca R, Maffei M, Barone M, Lori L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-32.
11. 11 Dessolin S, Schalling M, Champigny O, Lönnqvist F, Ailbaud G, Dani C et al. Leptin gene is expressed in rat brown adipose tissue at birth. FASEB J 1997; 11: 382-7.
12. 12 Green ED, Maffei M, Braden VV, Proenca R, DeSilva U, Zhang Y et al. The human obese (ob) gene: expression pattern and mapping on the physical, cytogenic, and genetic maps of chromosome 7. Genome Res 1995; 5: 5-12.
13. 13 Gwo-Hwa L, Proenca R, Montez JM. Caroll KM, Darvishzadeh JG, Lee JI et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379: 632-5.
14. 14 Lönnqvist F, Schalling M, Thörne A, Arner P. Leptin secretion from adipose tissue in women. Relationship to plasma levels gene expression. J Clin Invest 1997; 99: 2398-404.
15. 15 Stephens TW, Basinski M, Bristow M, Bue-Valleskey JM, Burgett SG, Craft L et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995; 377: 530-32.
16. 16 Emilsson V, Liu Y-L, Cawthorn MA, Morton NM, Davenport M. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 1997; 46: 313-16.
17. 17 Cohen B. Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996; 274: 1185-8.
18. 18 Kieffer TJ, Heller S, Leech CA, Holz GG, Habener JF. Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic β-cells. Diabetes 1997; 46: 1087-93.
19. 19 Chehab FF, Lim ME, Ronghua LU. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nature Genetics 1996; 12: 318-20.
20. 20 Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse ob protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-9.
21. 21 Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-43.
22. 22 Haalas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D et al. Weight-reduction effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-6.
23. 23 Ahima RS, Prabakaran D, Mantzoros C, Daqing QU, Lowell B, Maratos Flier E et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996; 382: 250-52.
24. 24 Tartaglia L, Dembski L, Weng X, Deng N, Culpepper J, Devos R et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995; 83: 1263-71.
25. 25 Golden PL, Maccagnan TJ, Pardridge WM. Human blood brain barrier leptin receptor. J Clin Invest 1997; 99: 14-18.
26. 26 Caro J, Kolazcynski JW, Nyce MR, Ohannesian JP. Opentatova I, Goldman WH et al. Decreased cerebrospinal-fluid/ serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996; 348: 159-61.
27. 27 Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D Jr Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans. Nature Med 1996; 2: 589-91.
28. 28 Woods AJ, Stock MJ. Leptin activation in hypothalamus. Nature 1996; 381: 745.
29. 29 Dourish CT, Rycroft W, Iversen SD. Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors. Science 1989; 245: 1509-11.
30. 30 Daquing QU, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ et al. A role for melatonin-concentrating hormone in the central regulation of feeding behaviour. Nature 1996; 380: 243-7.
31. 31 Elmquist JK, Ahima RS, Maratos-Flier E, Flier JS, Saper CB. Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinol 1997; 138: 839-42.
32. 32 Phillips MS, Liu Q, Hammond HA, Dugan V, Hey PJ. Caskey CT et al. Leptin receptor missence mutation in the fatty Zucker rat. Nature Genetics 1996; 13: 18-19.
33. 33 Gerald C, Walker MW, Criscione L, Gustafson EL. Batzl-Hartmann C, Smith KE et al. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 1996; 382: 168-71.
34. 34 Schwantz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y Gene expression in ob/ob mice. Diabetes 1996; 45: 531-5.
35. 35 Erickson JC, Clegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 1996; 381: 415-18.
36. 36 Montague CT, Farooqi IS, Whitehead JP, Soos MA, Ran H, Wareham NJ et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387: 903-8.
37. 37 Löonnqvist F, Arner P, Nordfors L, Schalling M. Over-expression of the obese (ob) gene in human obese subjects. Nature Med 1995; 1: 950-53.
38. 38 Hamilton BS, Paglia D, Kwan AYM, Deitel M. Increased obese mRNA expression in omental fat cells from massively obese humans. Nature Med 1995; 1: 953-6.
39. 39 Considine RV, Considine EL, Williams CJ, Nyce MR, Magosin SA, Bauer TL et al. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest 1995; 95: 2986-8.
40. 40 Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-redviced subjects. Nature Med 1995; 1: 1155-61.
41. 41 Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-5.
42. 42 Licinio J, Mantzoros C, Negrao AB, Cizza G, Wong M-L, Bongiorno PB et al. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nature Med 1997; 3: 575-9.
43. 43 Sinha MK, Ohannesian JP, Heiman ML, Kriauciunas A, Stephens TW, Magosin, et al. Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 1996; 97: 1344-7.
44. 44 Kolaczynski JW, Considine RV, Ohannesian JP, Marco C, Opentantova I, Nyce MR et al. Responses of leptin to short-term fasting and refeeding in humans: a link with ketogenesis but not ketones themselves. Diabetes 1996; 45: 1511-14.
45. 45 Hedebrand J, Blum WF, Barth N, Coners H, Englaro P, Juul A et al. Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short-term weight restoration. Mol Psychiatry 1997; 2: 330-34.
46. 46 Köpp W, Blum WF, von Prittwitz S, Ziegler A, Hubbert H, Emons G et al. Low leptin levels predict amenorrhea in underweight and eating disorderd females. Mol Psychiatry 1997; 2: 335-40.
47. 47 Sinha MK, Opentantova I, Ohannesian JP, Kolaczynski JW, Heiman ML, Hale J et al. Evidence of free and bound leptin in human circulation. J Clin Invest 1996; 98: 1277-82.
48. 48 Maffei M, Stoffel M, Barone M, Moon B, Dammerman M, Ravussin E et al. Absence of mutations in the human ob gene in obese/diabetic subjects. Diabetes 1996; 45: 679-82.
49. 49 Echwald SM, Sörensen TD, Sörensen TIA, Tybjaerg-Hansen A, Andersen T, Chung WK et al. Amino acid variants in the human leptin receptor: lack of association to juvenile onset obesity. Biochem Biophys Res Comm 1997; 233: 248-52.
50. 50 Clement K, Garner C, Hager J, Philippi A, LeDuc S, Carey A et al. Indication for linkage of the human ob gene region with extreme obesity. Diabetes 1996; 45: 691-4.
51. 51 Reed DR, Yuan Ding, Weizhen, ZU Cather, C Green, ED Price, RA Extreme obesity may be linked to markers flanking the human ob gene. Diabetes 1996; 45: 691-4.
52. 52 Commuzzic AG, Hixson JE, Almasy L, Mitchell BD, Mahaney MC, Dyer TD et al. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nature Genetics 1997; 15: 273-6.
53. 53 Comings DE, Gade R, MacMurray JP, Muhleman D, Peters VVR. Genetic variants of the human obesity (bh) gene: association with body mass index in young women, psychiatric symptoms, and interaction with the dopamine D2 receptor (DRD2) gene. Molec Psychiatry 1996; 1: 325-35.
54. 54 Haffner SM, Stern MP, Miettinen H, Wei M, Gingerich RL. Leptin concentrations in diabetic and nondiabetic Mexican-Americtins. Diabetes 1996; 45: 822-4.
55. 55 Stenvinkel P, Heimbürger O, Lönnqvist F. Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure. Nephrol Dial Transplant 1997; 12: 1321-5.
56. 56 Kolaczynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R et al. Acute and chronic effect of insulin on leptin production in humans. Diabetes 1996; 45: 699-701.
57. 57 Zakrzewska KE, Cusin I, Sainsbury A, Rohner-Jeanrenaud F, Jeanrenaud B. Glucocorticoids as counterregulatory hormones of leptin. Diabetes 1997; 46: 717-19.
58. 58 Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE. Spiegelman BM. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 1996; 274: 1377-9.
59. 59 Grunfeld C, Zhao C, Fuller J, Pollock A, Moser A, Friedman J et al. Endotoxin and cytokines induce expression of leptin, the ob gene product in hamsters. J Clin Invest 1996; 97: 2152-7.
60. 60 Heimbürger O, Lönnqvist F, Danielsson A, Nordenström J. Stenvinkel P. Serum Immunoreactive leptin concentrations and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 1997; 8: 1423-30.
61. 61 Anonymous Equivocal results for Amgen's leptin? Scrip 1997; 2243: 24.
62. 62 Zhang FM, Basinski MB, Beals JM, Briggs SL, Churgay LM, Clawson DK et al. Crystal structure of the obese protein leptin-E100. Nature 1997; 387: 206-9.
63. 63 Mantzoros CS, Daqing QU, Frederich RC, Susulic VS, Lowell BB, Maratos-Flier E et al. Activation of ß 3 adrenergic receptors supresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes 1996; 45: 909-14.
64. 64 Collins S, Surwit RS. Pharmacological manipulation of ob gene expression in a dietary model of obesity. J Biol Chem 1996; 16: 9437-40.
65. 65 Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyrueis C et al. Nature Genetics 1997: 15: 269-72.
66. 66 Boss O, Samee S, Paoloni-Giacobino A, Rossier C, Dulloo A, Seydoux J et al. Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Letters 1997; 408: 39-42.